Home » Fitness, Health & Medicine, Manufacturing & Industry, Marketing & Sales, World » eClinical Solutions Market To Surpass $13 Billion By 2024 – Industry Analysis by Hexa Research
“Fact-based market research, penetrating industry insights and validated forecasts to help you make better decisions for a stronger future”
Growing medical research programs in various Asian countries along with the development of low-cost modules are also projected to boost the “eClinical solutions market” growth.

Projected to grow at a CAGR of around 12%, eClinical solutions market is expected to witness significant growth over the forecast period owing to the increasing demand for software solutions for clinical trials by the pharma and biopharma companies.

Expanding research and development in this market is expected to drive the market growth over the forecast period. Also, increase in the government grants to substantiate the clinical trials and the rise in the number of customers for eClinical solutions is to spur the market growth over the forecast period. Moreover, factors such as the presence of a large population, growing customer base, low operating costs, and shift of resources from AMCs to CROs are propelling the growth of this market, especially in the Asia Pacific countries. The emerging markets, including Korea, China, Taiwan, and India, have become pleasing destinations for the outsourcing of clinical trials due to the presence of a large population and low service costs.

Some other factors influencing the growth of the market are intensive R&D activities resulting in the development and launch of new products, increasing government grants for clinical trials, and the rising prevalence of lifestyle diseases. In terms of growth rate, Asia Pacific is anticipated to witness a rapid growth in the global market. The increasing participation of emerging economies in the clinical trials is expected to fuel the growth of the market in the near future.

However, factors such as the high implementation cost, lack of awareness of clinical data sciences software in the research community, and scarcity of skilled research professionals are expected to hinder market growth.

Browse Related Category Market Reports @

Tissue Engineering Market

Portable X-Ray and CT Scan Devices Market

Parkinson’s Disease Therapeutics Market

The eClinical solutions market is segmented on the basis of product, delivery mode, clinical trial phases and end-user application. On the basis of product, the market consist of clinical analytics platforms, Electronic Clinical Outcome Assessment (ECOA), Electronic Data Capture (EDC),Clinical Data Management Systems (CDMS), clinical data integration platforms, safety solutions, Clinical Trial Management Systems (CTMS), Randomization and Trial Supply Management (RTSM), and electronic Trial Master File (eTMF). On the basis of delivery mode, the market include web-hosted, licensed enterprise, and cloud-based. The clinical trials phases are phase I, phase II, phase III, and phase IV. The end-user applications of this market are consulting service companies, medical device manufacturers, hospitals, contract research organizations, and pharmaceutical & biopharmaceutical companies.

The EDC and CDMS segments dominate the market currently whereas the eCOA segment is anticipated to witness the highest growth rate during the forecast period.

North America is estimated to dominate the market currently followed by Europe. One of the key factors attributing to the growth of the North American market is the increasing number of clinical trials being conducted in the region.

The key players in the market include Oracle Corporation, Parexel International Corporation, Medidata Solution, Inc., BioClinica, DataTrak International, Inc., CRF Health, ERT, eClinical Solutions, Merge Health Incorporated, and OmniComm Systems, Inc. In order to attain a competitive edge in the industry, the major players are actively involved in organic as well inorganic growth strategies. Agreements, collaborations, partnerships, and new product launches are some of the key strategies, which are implemented by the market players.

Table of Contents:

Chapter 1. Methodology and Scope

1.1. Research methodology

1.2. Research scope & assumption

1.3. List of data sources

Chapter 2. Executive Summary

2.1. eClinical Solutions Market – Industry Summary and Key Buying Criteria, 2016 – 2024

Chapter 3. eClinical Solutions Industry Outlook

3.1. Market segmentation

3.2. Market size and growth prospects, 2016-2024

3.3. eClinical Solutions: Market dynamics

      3.3.1. Market driver analysis

   Increasing externalization of clinical trial studies by the large biopharma and pharma companies

   Presence of a strong range of products in pipeline

      3.3.2. Market restraint analysis

   Scarcity of skilled research professionals

   Lack of recognition

3.4. eClinical solutions market: Industry trend analysis

3.5. eClinical solutions market: PESTEL Analysis

3.6. eClinical solutions industry analysis – Porter’s Five Forces Model

3.7. eClinical solutions: Company market share analysis (%), 2016

3.8. Key opportunities prioritized

Read Press Release on “eClinical Solutions Market” @


About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Media Contact
Company Name: Hexa Research
Contact Person: Michelle Thoras and Ryan Shaw
Email: sales@hexaresearch.com
Phone: +1-800-489-3075
Address:Felton Office Plaza, 6265 Highway 9
City: Felton
State: California
Country: United States
Website: www.hexaresearch.com/research-report/eclinical-solutions-market

Comments are closed.